CDISC instructors come from a variety of professional backgrounds and are located across seven countries and three continents. Our instructors work for pharmaceutical companies, CROs, consultancy firms, academic institutions and undergo a rigorous qualification process to teach CDISC-authorized courses.
Greater Clarity Starts with CDISC Education. We invite you to join us at one of our training events. You can also reach out to us with any questions you may have.
Nancy Brucken is a Standards Engineer on the Data Standards team at Clinical Solutions Group, Inc., responsible for ADaM implementation, compliance and internal tool development. She has been an ADaM team member since 2011, a contributor to the OCCDS v1.0, Rheumatoid Arthritis Therapeutic Area, ADaM IG v1.2 and Traceability sub-teams, serves as co-leader of the ADQRS sub-team, and received a CDISC award for Outstanding Contributions to Standards Development in 2017. Nancy has been a frequent presenter and seminar/workshop instructor on ADaM-related topics at various industry conferences.
Sally Cassells serves on CDISC’s Data Science Team as Senior Director of Data Exchange Standards. She leads the development of Data Exchange Standards and participates in work on CDISC Library. As a founding member of the Data Exchange Standards team, Sally contributed to the development of ODM and Define-XML from inception to current versions. Prior to joining CDISC, she provided technical consulting services for organizations implementing CDISC Data Exchange standards and spent over 25 years developing clinical research and drug safety software products at BBN Software, Belmont Research, Lincoln Technologies, Phase Forward and Oracle.
Nate Freimark is Vice President - Clinical Programming and Data Standards at The Griesser Group. Nate was the CDISC ADaM team lead from 2010-2017, a member of the CDISC GGG (Global Governance Group), one of the ADaM trainers and a member of the SDS Oncology, QS and Compliance subteams. Nate is also a member of several PhUSE teams (working on improving data quality and site selection standards) and the ADaM lead for many CFAST Therapeutic Area User Guides (TAUGs). He has been a member of the ADaM team since 2005, a member of the ADaM Leadership Team since it’s creation, and has been “doing CDISC” since 2004. Nate has been involved in ADaM Education since it’s inception from the development of the training material to giving public, private, and FDA ADaM training courses.
Nate is also a lead programmer who has worked on numerous projects involving the creation of SDTM and ADaM datasets (and associated defines) as well as the tables, listings, and graphs created based upon them dating back to 2004. He works closely with other project team members within The Griesser Group and outside of The Griesser Group to produce a quality product on time. He has extensive experience with a broad range of therapeutic areas including anti-infective, oncology, and pain management studies.
Nate has also been a liaison between integrating companies trying to figure out how best to move forward in a unified CDISC Compliant environment.
Kit Howard has over 30 years of experience in many facets of clinical research, including the development of data and process standards for exploratory through post-marketing clinical trials. She joined CDISC staff 6 years ago, but first volunteered with CDASH beginning in 2007. She is currently Senior Director of Education and Standards Development for CDISC, both developing and presenting online and classroom training. She is actively involved in data capture and regulatory submission data standards for drug, biologic and medical device research, with particular interest in their use by both regulated industry and academia. She serves as co-leader of CDISC’s Medical Device Standards Development team, as well as participating in CDASH, CDISC’s Global Governance Group, and most recently on CDISC’s COVID-19 development of guides for new and ongoing clinical research during the pandemic.
Kit is active in the professional community, speaking at conferences, presenting standards and quality-related talks and webinars. Prior to joining CDISC’s staff, she developing public health and clinical research informatics online courses for Michigan State University, and spent 10 years as Kestrel Consultants, where she guided research organizations in evaluating their data standards-readiness and in designing and implementing standards, specializing in "protocol through clinical study report" implementations that incorporated both process and CDISC standards.
Sam Hume leads the CDISC Data Science team, which collaborates with CDISC staff and stakeholders to develop tools and standards that support clinical and translational data science. Dr. Hume directs delivery of the CDISC Library, our standards metadata repository, co-leads the CDISC Data Exchange Standards team, and leads the CDISC Real World Data efforts. He has 25 years’ experience in clinical research informatics and has held a number of senior technology positions in the biopharmaceutical industry. Dr. Hume holds a doctorate in Information Systems.
Kristin Kelly is an Associate Director at Pinnacle 21 in the Clinical Data Standards group. Kristin has over 10 years of experience working in the pharmaceutical industry primarily focused on clinical data standards. Prior to joining Pinnacle, Kristin was an Associate Director at Merck in the Global Clinical Data Standards (GCDS) group. She was also worked a consultant in Data Standards Consulting (DSC) for Accenture (formerly Octagon Research Solutions). She provides guidance on CDASH and SDTM standards to both internal project teams and external clients. Kristin is also involved with the CDISC SDS team, CFAST Initiative TAUG teams, SEND Core Team, as well as several PhUSE CSS Working Groups. Kristin has led several SDTM conversion projects for submission to both CDER and CBER that have resulted in FDA approvals. Kristin holds a B.S. in Biology from Saint Joseph’s University.
Sandra is a Senior Principal Clinical Data Standards Consultant at PRA Health Sciences, helping implement ADaM. She is a former ADaM Team Lead, and previously led the ADaM sub-team for the Occurrence Data Structure (OCCDS) v1.0 and co-led the finalization of ADaMIG v1.1. An active ADaM team member since 2001, she proposed structures that later became ADSL and OCCDS and reviews draft ADaM documents with a focus on the fundamental principle of traceability. Sandra has worked in the pharma/biotech industry since 1993, at both sponsor and vendor organizations, in a variety of roles, including programmer, statistician, data manager, and filing team lead.
Mike Molter is the Director of Statistical Programming and Technology at Wright Avenue in Cary. At Wright Avenue, Mike is responsible for providing statistical programming support, as well as placing and managing Wright Avenue resources inside pharmaceutical, biotech, and CRO clients. He also oversees the management and development of new technologies aimed at streamlining the flow of clinical trial metadata through an organization.
Mike has been involved in SAS programming since 1999, in clinical trials since 2003, and in industry data standards since 2005. He has been a member of the CDISC XML Technologies team since 2010. Professional interests are centered around the use of cutting edge technologies to optimize the use of clinical trial metadata throughout the lifecycle of a clinical trial. Personal interests include cycling, swimming, and reading.
Dr. Erin Muhlbradt is a contractor for the US National Cancer Institute’s Enterprise Vocabulary Services (NCI EVS) and is the NCI EVS and CDISC project lead for CDISC terminology development. Dr. Muhlbradt has over 10 years’ experience in the bioinformatics and pharmaceutical industries, with skills including terminology development, standards development, database and metadata repository development, and data modeling.
She manages a team at EVS that is responsible for the development, publication, and maintenance of CDISC controlled vocabularies in use by the pharmaceutical industry and mandated by the US Food and Drug Administration (FDA) and Japanese Pharmaceuticals and Medical Devices Agency (PMDA). Her duties include project management, biomedical and clinical subject matter expertise, terminology development, quarterly terminology publications, and management of the CDISC terminology change request mechanism. Previously, Erin was a doctoral candidate at Georgetown University in the Tumor Biology department and she performed her thesis work in prostate cancer cell signaling in laboratories at Georgetown University (Washington, DC) and Columbia University (New York, NY).
Erin holds a Bachelor of Science Degree (Honors) in Molecular and Cellular Biology from the University of Glasgow (Glasgow, Scotland) and a Doctoral Degree in Tumor Biology from Georgetown University (Washington, DC).
Erin leads, co-leads, or oversees 19 active CDISC controlled terminology teams. She is a co-lead of the SDS PGx subteam, a co-lead of the SDS Cell Phenotyping sub-team, a voting member of the CDISC Global Governance Group (GGG), and a terminology representative on many active therapeutic area standards development teams.
Jerry is currently SDTM and CDASH Implementation Advisor for Data Standards Consulting, a Talent Mine Group. Jerry previously worked for the Accenture Life Sciences Data Standards Consulting group starting in January 2009 after 15 years in clinical data management at Procter and Gamble Pharmaceuticals. During his time with P&G, Jerry was involved in getting several new drugs and indications through the clinical-trial process and ultimate submission. He presented at numerous investigator meetings across the US and throughout Europe. With P&G, he was also active within the industry, representing P&G at the e-Clinical Forum (in both the US and Europe), where he presented a number of papers on electronic data capture and data warehousing.
With Accenture, Jerry provided internal consulting resources to the Data Standards and Integration department as well as the in-house data management group. He also worked one-on-one directly with several sponsors in review of mapping specifications (via CRFs and datasets) from source to SDTM-based datasets.
Lauren is a Certified Clinical Data Manager with over 15 years experience in data management, programming and project management. She has managed clinical and statistical programming teams in both North America and Europe and developed CRF standards for an international CRO as well as several client organizations. Lauren is the 2012 Chair of the CDISC Advisory Board and is part of the CDASH Leadership Team.
Jack Shostak manages a group of statistical programmers and is an Associate Director of Statistics at the Duke Clinical Research Institute. He is the author of SAS Programming in the Pharmaceutical Industry and coauthor of Common Statistical Methods for Clinical Research with SAS Examples, Third Edition as well as Implementing CDISC Using SAS: An End-to-End Guide, Second Edition. Jack has been active in CDISC since 2002 primarily as a contributor to ADaM model development. Jack serves as a member of the ADaM leadership team and has been a CDISC ADaM instructor for industry and the FDA for the past decade.
Gary Walker has worked in the pharmaceutical industry since 1992 and tells people his career path took the proverbial "scenic route." He started in IT and moved to R&D IT, supporting CANDA (Computer Assisted New Drug Applications) submissions. He subsequently moved to Regulatory Affairs and Publishing where Gary helped to create numerous NDAs, BLAs and supplements in electronic format from 1997 through 2005. In 2001, while working in regulatory, Gary became a member of the CDISC SDS team. In 2005 Gary moved from regulatory to Data Standards within Quintiles’ Global DM department. In this role, Gary supported CDISC standards for data preparation within DM and Biostatistics, both for submission using SDTM and in the data collection and cleaning processes of Data Management. Gary joined the CDASH initiative in 2006 and has been a core member of CDASH since. In 2019 Gary became an independent contractor, consulting and training on CDISC standards. He continues to actively participate on the work on many of the CDISC standards including SDTM, CDASH and CDISC SHARE. Prior to leaving Quintiles (now IQVIA), Gary worked within the Innovation group which was focused on new and innovative products, and was part of a team focused on EHR data use for clinical research.
Richann Watson is an independent statistical programmer and CDISC consultant with over 20 years’ experience working in the pharma industry. She is a member of the ADaM team, co-leads the ADaM Oncology sub-team and serves on the ADaM Traceability sub-team. Richann is an Executive Committee member of PharmaSUG. She is also a member of Southeast SAS Users Group (SESUG) Executive Committee and is actively involved with SAS Global Forum and other SAS User Groups.
Mario Widel is an Independent CDISC consultant. He has been doing statistical programming since 1992. He has been involved in CDISC related activities since 2007 on a previous company having a key role in the transition to CDISC standards CDASH, SDTM and ADaM. In his current role, Mario oversees and reviews submission deliverables including aCRF, SDTM, ADaM and define.xml.
He received his M.S. degree on Computer Science from the University of Illinois at Chicago. He is a regular presenter at conferences like JSM, PharmaSUG, SAS Global Forum, PhUSE and CDISC and a member of ASA and the CDISC ADaM team.
Diane Wold is Senior Director, Standards Development and Modeling at CDISC. She came to CDISC in 2015 with 30 years of experience in the pharmaceutical industry in statistics and data standards. She has been an SDS team member since 2002, and led the development of the trial design model within the SDTM. She was a member of the Protocol Representation Group and the early SHARE project. She worked on the development of the BRIDG model and the mapping of the SDTMIG to BRIDG. She has worked on numerous Therapeutic Area User Guides, where she introduced the use of concept maps. She has been involved in the review and governance of CDISC standards since 2012.
Fred is Senior Manager and Lead of the Data Standards Consulting Group within Accelerated R&D Services, a group he has led since 2007. He has been active in leading the development of CDISC standards since 1999. He is one of the principal contributors to the CDISC Study Data Tabulation Model (SDTM). Fred is a founding member of the SDS Team (1999), the SEND Team (2002), and the Devices Team (2007), and has led or co-led these for many years; he currently serves on the Leadership Teams of all three. Fred is currently a member of the CDISC Standards Review Council (SRC), the CDISC SDTM Governance Committee (SGC), and the CDISC Technical Leadership Committee (TLC). He has been a member of many other CDISC SDTM-related teams since 1999, and is providing SDTM expertise to therapeutic-area projects conducted as part of the CFAST initiative.
Fred joined Accenture via the Octagon acquisition in 2012. He joined Octagon in 2006, coming from Procter & Gamble Pharmaceuticals, where he was the Global Data Standards Manager in the Clinical Data Management Department. This position was preceded by many years as a Senior Toxicologist at P&G, supporting Rx and OTC products. Fred has a Ph.D. and an M.S. in Biochemistry from the University of Massachusetts in Amherst, and a B.S. in Biology from Springfield College in Springfield, Massachusetts.